Recipharm announced Marc Funk, who successfully led the company into its next phase of growth, will join the board of directors, where he will continue to support the Group. Marc will remain on the Board of NewBiologix as well as CEO and Board Member of MarBio, Recipharm's vaccine sterile fill and finish joint venture with the Kingdom of Morocco. This will allow Marc to extend his support to bolster the African continent's capabilities in the production of biological medicines and vaccines, with the ultimate objective of helping the continent to be more self-reliant in the event of future pandemics.